Assignee
CHONGQING CLARUVIS PHARMACEUTICAL CO LTD
CN·0 granted patents·5 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
5 records- 0165US2025222081A1Botulinum toxin protein composition, method for preparing same, and use thereofCHONGQING CLARUVIS PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0264US2024228534A9Cell lysis buffer separation apparatus for preparing polypeptide, and system and application thereofCHONGQING CLARUVIS PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0361US2024228533A9Preparation method for modified toxin polypeptideCHONGQING CLARUVIS PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0461US2024415968A1Botulinum toxin protein compositionCHONGQING CLARUVIS PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0560US2024226250A9Modified neurotoxin single-chain polypeptide and use thereofCHONGQING CLARUVIS PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CHONGQING CLARUVIS PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →